ArticleMolecular oncology2025

BMP antagonist CHRDL2 enhances the cancer stem-cell phenotype and increases chemotherapy resistance in colorectal cancer.

Eloise Clarkson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.